Trade vTv Therapeutics Inc. - VTVT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.59 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 20.93 |
| Open | 21.54 |
| 1-Year Change | 3265.63% |
| Day's Range | 20.63 - 21.68 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 20.96 | -2.33 | -10.00% | 23.29 | 24.13 | 20.51 |
| Jul 24, 2024 | 23.47 | 1.29 | 5.82% | 22.18 | 23.64 | 22.18 |
| Jul 23, 2024 | 22.91 | -0.01 | -0.04% | 22.92 | 24.19 | 22.11 |
| Jul 22, 2024 | 22.59 | 1.34 | 6.31% | 21.25 | 22.92 | 20.80 |
| Jul 19, 2024 | 20.32 | -0.10 | -0.49% | 20.42 | 20.42 | 20.32 |
| Jul 18, 2024 | 20.80 | -2.71 | -11.53% | 23.51 | 23.51 | 20.80 |
| Jul 17, 2024 | 22.43 | -1.58 | -6.58% | 24.01 | 24.01 | 21.74 |
| Jul 16, 2024 | 23.23 | 0.45 | 1.98% | 22.78 | 24.01 | 22.78 |
| Jul 15, 2024 | 24.53 | 2.36 | 10.65% | 22.17 | 24.53 | 22.17 |
| Jul 12, 2024 | 22.56 | 0.74 | 3.39% | 21.82 | 24.04 | 21.82 |
| Jul 11, 2024 | 20.41 | -0.34 | -1.64% | 20.75 | 21.30 | 20.06 |
| Jul 10, 2024 | 21.52 | 1.10 | 5.39% | 20.42 | 21.52 | 20.42 |
| Jul 9, 2024 | 20.02 | 1.58 | 8.57% | 18.44 | 20.02 | 18.02 |
| Jul 8, 2024 | 18.23 | -0.06 | -0.33% | 18.29 | 18.29 | 17.04 |
| Jul 5, 2024 | 17.03 | -0.61 | -3.46% | 17.64 | 17.64 | 17.03 |
| Jul 3, 2024 | 18.15 | -0.24 | -1.31% | 18.39 | 18.48 | 17.63 |
| Jul 2, 2024 | 18.03 | 0.59 | 3.38% | 17.44 | 18.74 | 17.44 |
| Jul 1, 2024 | 17.53 | -0.80 | -4.36% | 18.33 | 18.43 | 17.53 |
| Jun 28, 2024 | 16.98 | 0.50 | 3.03% | 16.48 | 17.03 | 16.48 |
| Jun 27, 2024 | 17.23 | 0.90 | 5.51% | 16.33 | 17.28 | 16.33 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
vTv Therapeutics Inc. Company profile
About vTv Therapeutics Inc
vTv Therapeutics Inc. is a clinical-stage pharmaceutical company that is engaged in the discovery and development of orally administered small molecule drug candidates. It is developing a program for the treatment of type I diabetes TTP399 and for psoriasis HPP737. TTP399 is an orally administered, small molecule, liver-selective glucokinase activator (GKA) in development potential oral anti-diabetic for the treatment of type I diabetes. TTP399 completed the SimpliciT-I Study, a Phase II trial in patients with type I diabetes as an add-on to insulin therapy. The Company is also conducting a multiple ascending dose Phase I study of HPP737, an orally administered phosphodiesterase type IV inhibitor, to assess the pharmacokinetics, pharmacodynamics, safety and tolerability of HPP737 in healthy volunteers as part of its psoriasis program. Its TTP273 is an oral, small molecule, glucagon-like peptide I (GLP-1) receptor agonist being evaluated for the treatment of type II diabetes mellitus.
Financial summary
BRIEF: For the nine months ended 30 September 2021, vTv Therapeutics Inc revenues increased from $15K to $4M. Net loss decreased 38% to $5.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other (expense) income increase from $0K to $1.8M (income), Research and Development - Balancing decrease of 10% to $7.4M (expense).
| Industry: | Bio Therapeutic Drugs |
3980 Premier Dr
Suite 310
27265
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com